FT Weekend: A new weight-loss drug works. Is ...

China is bypassing shipping chokepoints with an “Ice Silk Road” route through the Arctic, dozens of people have been killed in election clashes in Pakistan-administered Kashmir, and Germany’s economy minister warned that growing support for a far-right political party could deter ...  Show more

Weakened refining capacity in Russia and the Gulf is a boon to US refiners. Plus, the Trump administration’s decision to revoke legal protections for migrants could hurt the US economy, and Google is shifting control of its AI effort from London back to Silicon Valley.Mentioned i ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ...  Show more